BG62875B1 - Циклоспоринови състави за орално приемане - Google Patents

Циклоспоринови състави за орално приемане Download PDF

Info

Publication number
BG62875B1
BG62875B1 BG101443A BG10144397A BG62875B1 BG 62875 B1 BG62875 B1 BG 62875B1 BG 101443 A BG101443 A BG 101443A BG 10144397 A BG10144397 A BG 10144397A BG 62875 B1 BG62875 B1 BG 62875B1
Authority
BG
Bulgaria
Prior art keywords
composition
cyclosporine
cyclosporin
carbon atoms
solvent
Prior art date
Application number
BG101443A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101443A (en
Inventor
Moo Cho
Ralph Levy
Philippe Pouletty
Robert Floch
Christian Merle
Original Assignee
Sangstat Medical Corporation
University Of North Carolina At Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/519,689 external-priority patent/US5834017A/en
Priority claimed from US08/620,021 external-priority patent/US5766629A/en
Priority claimed from US08/622,516 external-priority patent/US5827822A/en
Application filed by Sangstat Medical Corporation, University Of North Carolina At Chapel Hill filed Critical Sangstat Medical Corporation
Publication of BG101443A publication Critical patent/BG101443A/xx
Publication of BG62875B1 publication Critical patent/BG62875B1/bg

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BG101443A 1995-08-25 1997-04-25 Циклоспоринови състави за орално приемане BG62875B1 (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/519,689 US5834017A (en) 1995-08-25 1995-08-25 Oral cyclopsporin formulations
US08/620,021 US5766629A (en) 1995-08-25 1996-03-21 Oral cyclosporin formulations
US08/622,516 US5827822A (en) 1996-03-25 1996-03-25 Cyclosporin a formulations as nanoparticles
PCT/US1996/012569 WO1997007787A1 (en) 1995-08-25 1996-07-31 Oral cyclosporin formulations

Publications (2)

Publication Number Publication Date
BG101443A BG101443A (en) 1998-03-31
BG62875B1 true BG62875B1 (bg) 2000-10-31

Family

ID=27414735

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101443A BG62875B1 (bg) 1995-08-25 1997-04-25 Циклоспоринови състави за орално приемане

Country Status (27)

Country Link
EP (1) EP0789561B1 (no)
JP (1) JP3009742B2 (no)
KR (1) KR100294935B1 (no)
CN (1) CN1164828A (no)
AR (1) AR001985A1 (no)
AT (1) ATE263550T1 (no)
AU (1) AU709548B2 (no)
BG (1) BG62875B1 (no)
BR (1) BR9606603A (no)
CA (1) CA2202887A1 (no)
CZ (1) CZ124897A3 (no)
DE (2) DE69632125T2 (no)
ES (1) ES2129381T1 (no)
GE (1) GEP20012547B (no)
HK (1) HK1001956A1 (no)
HU (1) HUP9801052A3 (no)
IL (1) IL120673A0 (no)
IS (1) IS4460A (no)
MX (1) MX9702809A (no)
NO (1) NO971890D0 (no)
NZ (1) NZ313899A (no)
PL (1) PL319898A1 (no)
RO (1) RO119815B1 (no)
SI (1) SI9620014A (no)
SK (1) SK53697A3 (no)
TW (1) TW460287B (no)
WO (1) WO1997007787A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
AU6461898A (en) * 1997-03-12 1998-09-29 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
JP2001520170A (ja) 1997-10-16 2001-10-30 ボード・オヴ・リージェンツ,ザ・ユニヴァーシティ・オヴ・テキサス・システム Nf−at3機能に関連した心肥大動物モデルと治療法
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
ATE437629T1 (de) * 2001-10-19 2009-08-15 Isotechnika Inc Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
CA2683415C (en) * 2007-04-04 2020-12-08 Sigmoid Pharma Limited An oral pharmaceutical composition
ES2963291T3 (es) 2007-04-26 2024-03-26 Sublimity Therapeutics Ltd Fabricación de múltiples minicápsulas
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
EP2432455B1 (en) 2009-05-18 2014-11-12 Sigmoid Pharma Limited Composition comprising oil drops
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
ES2858517T3 (es) 2014-11-07 2021-09-30 Sublimity Therapeutics Ltd Composiciones que comprenden ciclosporina
CN104940132B (zh) * 2015-06-05 2018-02-27 河南牧翔动物药业有限公司 一种硫酸小檗碱口服液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
ES2168271T3 (es) * 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
ATE218359T1 (de) * 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung

Also Published As

Publication number Publication date
NO971890L (no) 1997-04-24
CA2202887A1 (en) 1997-03-06
WO1997007787A1 (en) 1997-03-06
ATE263550T1 (de) 2004-04-15
MX9702809A (es) 1998-02-28
CN1164828A (zh) 1997-11-12
GEP20012547B (en) 2001-10-25
SI9620014A (sl) 1998-04-30
EP0789561A1 (en) 1997-08-20
TW460287B (en) 2001-10-21
HUP9801052A2 (hu) 1998-09-28
BR9606603A (pt) 1997-09-30
AR001985A1 (es) 1998-01-07
AU709548B2 (en) 1999-09-02
AU6644196A (en) 1997-03-19
HK1001956A1 (en) 1998-07-24
BG101443A (en) 1998-03-31
NO971890D0 (no) 1997-04-24
SK53697A3 (en) 1997-10-08
ES2129381T1 (es) 1999-06-16
EP0789561B1 (en) 2004-04-07
NZ313899A (en) 2000-03-27
PL319898A1 (en) 1997-09-01
IS4460A (is) 1997-04-08
IL120673A0 (en) 1997-08-14
JPH10509462A (ja) 1998-09-14
EP0789561A4 (en) 1998-12-02
HUP9801052A3 (en) 1998-12-28
KR970706803A (ko) 1997-12-01
RO119815B1 (ro) 2005-04-29
CZ124897A3 (en) 1997-09-17
DE69632125T2 (de) 2004-09-16
DE69632125D1 (de) 2004-05-13
DE789561T1 (de) 1999-06-10
JP3009742B2 (ja) 2000-02-14
KR100294935B1 (ko) 2001-07-12

Similar Documents

Publication Publication Date Title
US6254885B1 (en) Oral cyclosphorin formulations
RU2174405C2 (ru) Композиция циклоспорина для перорального введения (варианты) и способ достижения иммуносупрессии в организме реципиента
BG62875B1 (bg) Циклоспоринови състави за орално приемане
NL194781C (nl) Farmaceutisch preparaat voor orale toediening dat een cyclosporine bevat.
KR0170769B1 (ko) 신규한 사이클로스포린 갈렌 제제
US5834017A (en) Oral cyclopsporin formulations
HUT70947A (en) Injectable rapamycin solutions and process for producing them
MXPA97002809A (es) Formulaciones orales de ciclosporina
RU2178293C2 (ru) Фармацевтическая композиция, содержащая циклоспорин, способ получения мягких желатиновых капсул
KR100308779B1 (ko) 사이클로스포린을함유한신규조성물
RU2172183C2 (ru) Оральные циклоспориновые составы
AU762963B2 (en) Cyclosporin solution
AU764599B2 (en) Oral cyclosporin formulations
JP2022526833A (ja) 浸透性が低いタンパク質、ペプチド、及び小分子の経口送達用の製剤
NZ502344A (en) Oral cyclosporin compositions wherein it is a suspension of less than 1 micrometer, non-ionic polyoxyalkylene surfactant and one alkanol solvent
CZ233799A3 (cs) Perorální farmaceutické přípravky cyklosporinu
KR0173349B1 (ko) 사이클로스포린-함유 고체 분산체 조성물
RU2207870C2 (ru) Фармацевтическая композиция, включающая циклоспорин в качестве активного ингредиента
WO2000067772A1 (en) Galenic formulations of argatroban for subcutaneous administration